MedPath

University of Navarra

University of Navarra logo
🇪🇸Spain
Ownership
Private
Established
1952-01-01
Employees
5K
Market Cap
-
Website
http://www.unav.edu

Clinical Trials

2

Active:1
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Lifestyles and Breast Cancer

Not Applicable
Active, not recruiting
Conditions
Malignant Tumor of Breast
First Posted Date
2019-11-22
Last Posted Date
2024-12-30
Lead Sponsor
University of Navarra
Target Recruit Count
766
Registration Number
NCT04174391
Locations
🇪🇸

University of Cantabria, Santander, Cantabria, Spain

🇪🇸

University of Navarra-Instituto de Investigación Sanitaria de Navarra, Pamplona, Navarra, Spain

🇪🇸

Instituto de Investigación Biosanitaria de Granada ibs.GRANADA, Granada, Spain

and more 1 locations

Programa PUEDES Infancia

Not Applicable
Completed
Conditions
Self Efficacy
Parenting
Life Style
First Posted Date
2018-10-05
Last Posted Date
2018-10-05
Lead Sponsor
University of Navarra
Target Recruit Count
23
Registration Number
NCT03698110
Locations
🇪🇸

Universidad de Navarra, Pamplona, Navarra, Spain

News

Ivermectin Mass Treatment Reduces Malaria Transmission by 26% in Landmark BOHEMIA Trial

The BOHEMIA trial, the largest study on ivermectin for malaria to date, demonstrated a 26% reduction in new malaria infections when administered alongside standard bed nets in Kenya.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.